T1	Participants 68 105	chronic obstructive pulmonary disease
T2	Participants 261 305	chronic obstructive pulmonary disease (COPD)
T3	Participants 460 464	COPD
T4	Participants 499 511	204 patients
T5	Participants 2258 2276	patients with COPD
